Day One Biopharmaceuticals shares jump 23% on positive results for glioma treatmentMarket Watch • 06/05/23
Day One Announces New FIREFLY-1 Data for Tovorafenib (DAY101) and Initiation of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade GliomaGlobeNewsWire • 06/04/23
Day One to Participate in the Goldman Sachs 44th Annual Healthcare ConferenceGlobeNewsWire • 05/30/23
CORRECTION -- Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 05/26/23
Day One Announces Tovorafenib (DAY101) Data and Additional Abstracts to be Presented at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 05/25/23
Day One Biopharmaceuticals stock rallies as 1Q results show the brain tumor treatment candidate producer is funded into 2025Proactive Investors • 05/01/23
Day One Announces Abstracts Accepted for Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingGlobeNewsWire • 04/26/23
Day One Announces Upcoming Presentation at 19th European Association of Dermato-Oncology (EADO) CongressGlobeNewsWire • 04/12/23
Day One Biopharmaceuticals: Strong Potential, Price Drop Opportunity, Some ConcernsSeeking Alpha • 04/07/23
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate ProgressGlobeNewsWire • 03/06/23
Day One Announces Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade GliomaGlobeNewsWire • 01/08/23
Day One to Participate in the Piper Sandler 34th Annual Healthcare ConferenceGlobeNewsWire • 11/17/22
Day One Announces Upcoming Presentations at 2022 Society for Neuro-Oncology Annual MeetingGlobeNewsWire • 11/11/22
Day One Announces Cooperative Research and Development Agreement with National Cancer Institute to Expand Development of Tovorafenib (DAY101)GlobeNewsWire • 10/17/22
Foundation Medicine and Day One Biopharmaceuticals Announce Global Collaboration to Advance Pediatric Cancer CareBusiness Wire • 09/21/22
Day One to Participate in the 2022 Wedbush PacGrow Healthcare Virtual ConferenceGlobeNewsWire • 08/02/22